ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Ankylosing spondylitis (AS)"

  • Abstract Number: 103 • 2015 ACR/ARHP Annual Meeting

    Axial Disease in Psoriatic Arthritis: Genetic Biomarkers of Psoriatic Spondyloarthritis

    Deepak R. Jadon1, John Bowes2, Anne Barton3, Raj Sengupta1, Alison L Nightingale4, Mark Lindsay5, Eleanor Korendowych1, Graham Robinson6 and Neil J. McHugh7, 1Rheumatology, Royal National Hospital for Rheumatic Diseases, Bath, United Kingdom, 2Arthritis Research UK Centre for Genetics and Genomics, The University of Manchester, Centre for Musculoskeletal Research, Manchester, United Kingdom, 3Arthritis Research UK Centre for Genetics and Genomics, Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, The University Of Manchester, Manchester, United Kingdom, 4Pharmacy and Pharmacology, University of Bath, Bath, United Kingdom, 5Pharmacy & Pharmacology, University of Bath, Bath, United Kingdom, 6Royal United Hospital, Bath, United Kingdom, 7Rheumatology, Royal National Hospital for Rheumatic Diseases, Upper Borough Walls, United Kingdom

    Background/Purpose: A lack of well-characterised clinical cohorts has impeded research of the genetics of axial disease in psoriatic arthritis (PsA). We sought to determine genetic…
  • Abstract Number: 1276 • 2015 ACR/ARHP Annual Meeting

    Improvement in Work and Household Productivity for Patients with Rheumatoid Arthritis and Ankylosing Spondylitis Treated with Anti-TNFs in Routine Clinical Practice in Turkey

    Sebnem Ataman1, Mehmet Kirnap2, Buminhan Seferoglu3, Zuhal Altay4, Aylin Rezvani5, Omer Kuru6,7, Erhan Capkin8, Nazli Derya Bugdayci9, Ilhan Sezer10, Hasan Fatih CAY11 and Akinci Tan12, 1Rheumatology Department, Ankara University Faculty of Medicine, Ankara, Turkey, 2Department of Physical Medicine and Rehabilitation, Erciyes University, Kayseri, Turkey, 3Physical Medicine and Rehabilitation, Ataturk University Medical School, Erzurum, Turkey, 4ELAZIG KARAYOLU UZERI, Inonu University, Turgut Ozal Medical Center, Malatya, Turkey, 5Department of Physical Medicine and Rehabilitation, Bezmialem Foundation University, İstanbul, Turkey, 6Kurupelit Mevkii Kurupelit 552, Ondokuz Mayis Univ.Tip Fak.Has.-Fizik Tedavi, Samsun, Turkey, 7Physical Medicine and Rehabilitation, Ondokuz Mayis University, Samsun, Turkey, 8PM&R AND RHEUMATOLOGY, Karadeniz Tecnical University, Faculty of Medicine, TRABZON, Turkey, 9Physical Treatment and Rehabilitation, Istanbul Physical Treatment and Rehabilitation Training and Research Hospital, Istanbul, Turkey, 10Rheumatology, Physical Medicine and Rheabilitation, Antalya Education and Research Hospital, Antalya, Turkey, 11Rheumatology, Physical Medicine&Rehabilitation, Antalya Education and Research Hospital, Antalya, Turkey, 12Physical Med & Rehab, Hacettepe Univ, Ankara, Turkey

    Background/Purpose: The impact of  rheumatoid arthritis (RA) and ankylosing spondylitis (AS)  on paid work is measured on the basis of employed people missing time from…
  • Abstract Number: 1745 • 2015 ACR/ARHP Annual Meeting

    Predictors of Sustained Remission on Anti-TNF in an Observational Cohort of Patients with Ankylosing Spondylitis: The Role of MRI Parameters of Inflammation and Structural Damage

    Susanne Juhl Pedersen1, Stephanie Wichuk2, Praveena Chiowchanwisawakit3, Zheng Zhao4, Sasha Bernatsky5, Robert GW Lambert6, Barbara Conner-Spady7, Don Spady8 and Walter Maksymowych9, 1Copenhagen Center for Arthritis Research, Glostrup Hospital, University of Copenhagen, Copenhagen, Denmark, 2Department of Medicine, Medicine, University of Alberta, Edmonton, AB, Canada, 3Rheumatology, Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand, 4Rheumatology, Chinese PLA General Hospital, Beijing, China, 5Rheum/Clin. Epid., McGill MUHC/RVH, Montreal, QC, Canada, 6Department of Radiology & Diagnostic Imaging, Radiology, University of Alberta, Edmonton, AB, Canada, 7Medicine, Medicine, University of Alberta, Edmonton, AB, Canada, 8Medicine, University of Alberta, Edmonton, AB, Canada, 9Medicine/Rheumatic Dis Unit, Medicine, University of Alberta, Edmonton, AB, Canada

    Background/Purpose: Sustained clinical remission is one of the key benchmarks for treatment of AS over the long term. We aimed to determine the factors predictive…
  • Abstract Number: 2877 • 2015 ACR/ARHP Annual Meeting

    What Is the Location of Enthesitis in Ankylosing Spondylitis and Psoriatic Arthritis Patients and How Do They Respond to Anti-TNF Treatment?

    John Kelsall1, Denis Choquette2, Proton Rahman3, Regan Arendse4, Michelle Teo5, Isabelle Fortin6, J Antonio Avina-Zubieta7, Emmanouil Rampakakis8,9, Eliofotisti Psaradellis9, Karina Maslova10, Brendan Osborne11, Cathy Tkaczyk11, Francois Nantel12 and Allen J Lehman10, 1Mary Pack Arthritis Centre, Vancouver, Vancouver, BC, Canada, 2Rheumatology Department, Institut de Rhumatologie de Montréal and University of Montreal, Montreal, QC, Canada, 3Medicine, Memorial University, St John's, NF, Canada, 4University of Saskatchewan, Saskatoon, SK, Canada, 5Rheumatology, Penticton Regional Hospital, Penticton, BC, Canada, 6Centre de Rhumatologie de l'Est du Québec, Rimouski, QC, Canada, 7Arthritis Research Canada, Richmond, BC, Canada, 8JSS Medical Research, St-Laurent, QC, Canada, 9JSS Medical Research, Montreal, QC, Canada, 10Janssen Inc., Toronto, ON, Canada, 11Medical Affairs, Janssen Inc., Toronto, ON, Canada, 1219 Green belt Dr, Janssen Inc., Toronto, ON, Canada

    Background/Purpose: Enthesitis is characterized by inflammation at the insertion of ligaments, tendons, joint capsule, or fascia to bone, and represents a well-known characteristic feature of…
  • Abstract Number: 354 • 2015 ACR/ARHP Annual Meeting

    Association Between Bone and Clinical Parameters in Ankylosing Spondylitis

    Vladimira Boyadzhieva1, Mariana Ivanova2, Nikolay Stoilov1, Rumen Stoilov3, Rasho Rashkov4, Didier Hans5 and Rozier Berengere5, 1Rheumatology, University Hospital (MHAT) St Ivan Rilski, Sofia, Bulgaria, 2University Hospital "St. Iv. Rilski", Clinic of Rheumatology, Sofia, Bulgaria, 3University Hospital (MHAT) St Ivan Rilski, Sofia, Bulgaria, 4Department of Rheumatology, MHAT Sveti Ivan Rilski, Sofia, Bulgaria, 5Center of Bone Diseases, Lausanne University Hospital, Lausanne, Switzerland

    Background/Purpose: Ankylosing spondylitis (AS) is a chronic inflammatory rheumatological disease of unknown origin that primarily affects the axial skeleton, including the sacroiliac joints and spine,…
  • Abstract Number: 1629 • 2015 ACR/ARHP Annual Meeting

    Non-Interventional Clinical Study Investigating the Use of Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis in Germany – 3rd Interim Analysis

    Matthias H. Thomas1, Klaus Krüger2, Pee Aries3, Martin Bohl-Buehler4, Jan Brandt-Juergens5, Verena Rickert6 and Siegfried Wassenberg7, 1Medical Affairs, MSD Sharp & Dohme GmbH, Bünde, Germany, 2Praxiszentrum St. Bonifatius, München, Germany, 3Rheumatologie im Struenseehaus, Hamburg, Germany, 4Friedrich-Ebert-Str. 35, Rheumahaus, Potsdam, Germany, 5Praxis Brandt-Juergens/Karberg, Berlin, Germany, 6Medical Affairs, MSD Sharp&Dohme GmbH, Haar, Germany, 7Fachkrankenhaus, Ratingen, Germany

    Background/Purpose: Golimumab (GOL) has shown its efficacy and safety in various randomized clinical trials with accurately selected patients. Data from daily clinical practice in Germany…
  • Abstract Number: 1747 • 2015 ACR/ARHP Annual Meeting

    Predictors of Survival on Anti-TNF in an Observational Cohort of Patients with Ankylosing Spondylitis: The Role of MRI Parameters of Inflammation and Structural Damage

    Walter Maksymowych1, Zheng Zhao2, Stephanie Wichuk1, Praveena Chiowchanwisawakit3, Robert G Lambert4, Sasha Bernatsky5, Barbara Conner-Spady1, Donald Spady1 and Susanne Juhl Pedersen6, 1Medicine, Medicine, University of Alberta, Edmonton, AB, Canada, 2Rheumatology, Chinese PLA General Hospital, Beijing, China, 3Rheumatology, Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand, 4Radiology, Radiology, University of Alberta, Edmonton, AB, Canada, 5Rheum/Clin. Epid., McGill MUHC/RVH, Montreal, QC, Canada, 6Copenhagen Center for Arthritis Research, Glostrup Hospital, University of Copenhagen, Copenhagen, Denmark

    Background/Purpose: There has been no data reported evaluating MRI parameters of inflammation and structural damage. We aimed to identify factors influencing survival on anti-TNF therapy…
  • Abstract Number: 2882 • 2015 ACR/ARHP Annual Meeting

    Baseline Extent of Damage at the Spine Predicts Radiographic Progression in Korean Patients Using Golimumab for Ankylosing Spondylitis

    Jeong Seok Lee1, Dae Young Yu2, Stephen Xu3 and Eun Young Lee4, 1Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul National University Hospital, Seoul, South Korea, 2Medical Affairs, Janssen Korea, Seoul, South Korea, 3Janssen Research & Development, LLC, Spring House, PA, 4Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea

    Background/Purpose: Ankylosing spondylitis (AS) is a chronic rheumatic disease associated with radiographic damage of the spine. Golimumab had consistent efficacy in controlling disease activity through…
  • Abstract Number: 591 • 2015 ACR/ARHP Annual Meeting

    Rosuvastatin Improves Endothelial Function in Patients with Inflammatory Joint Diseases, Longitudinal Associations with Atherosclerosis and Arteriosclerosis

    Eirik Ikdahl1, Jonny Hisdal2, Silvia Rollefstad1, Inge C Olsen3, Tore K. Kvien4, Terje R. Pedersen5 and Anne Grete Semb6, 1Preventive Cardio-Rheuma Clinic, Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 2Section of Vascular Investigations, Oslo University Hospital Aker, Oslo, Norway, 3Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 4Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 5Department of Preventive Cardiology, Ullevaal University Hospital, Oslo, Norway, 6Preventive Cardio-Rheuma clinic, Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway

    Background/Purpose: Endothelial dysfunction is an early step in the formation of atherosclerotic lesions and can be quantified by the degree of flow mediated vasodilation (FMD)…
  • Abstract Number: 1686 • 2015 ACR/ARHP Annual Meeting

    Body Mass Index Is Associated with Hip Arthritis in Patients with Ankylosing Spondylitis

    Hyemin Jeong1, Jiwon Hwang2, Young Hee Eun1, Eun-Jung Park3, Ji-Min Oh4, Hyungjin Kim5, Joong Kyong Ahn6, Jaejoon Lee1, Chan Hong Jeon7, Eun-mi Koh8 and Hoon-Suk Cha9, 1Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, 2Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea, 3Department of Medicine, Jeju National University Hospital, Jeju University School of Medicine, Jeju, South Korea, 4Anyang SAM Hospital, Anyang, South Korea, 5Department of medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, 6Department of Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, South Korea, 7Department of Internal Medicine, Soonchunhyang University College of Medicine, Bucheon, South Korea, 8Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea, 9Division of Rheumatology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea

    Background/Purpose: To evaluate the clinical courses and associated factors of hip arthritis in patients with ankylosing spondylitis (AS). Methods: In this retrospective analysis, we evaluated…
  • Abstract Number: 1748 • 2015 ACR/ARHP Annual Meeting

    Degenerative Changes at the Lumbar Spine in Patients with Axial Spondyloarthritis and Non-Specific Mechanical Low Back Pain: A Magnetic Resonance Imaging Study

    Serkan Senol1, Gamze Kilic2, Sevgi Baspinar2, Erkan Kilic3 and Salih Ozgocmen4, 1Division of Neuroradiology, Erciyes University, Faculty of Medicine, Radiology, Kayseri, Turkey, 2Dept. PRM, Erciyes University, Faculty of Medicine,Division of Rheumatology, Kayseri, Turkey, 3Dept PRM, Erciyes University, Faculty of Medicine,Division of Rheumatology, Kayseri, Turkey, 4Dept.PRM, Erciyes University, Faculty of Medicine,Division of Rheumatology, Kayseri, Turkey

    Background/Purpose: Magnetic resonance imaging (MRI) has become an invaluable tool for early diagnosis of axial spondyloarthritis (axSpA) and several MRI-based studies have identified SpA-related inflammatory…
  • Abstract Number: 2887 • 2015 ACR/ARHP Annual Meeting

    Safety and Tolerability of Secukinumab in Patients with Active Ankylosing Spondylitis: Pooled Safety Analysis of Two Phase 3, Randomized, Controlled Trials

    Atul A. Deodhar1, Dominique Baeten2, Joachim Sieper3, Brian Porter4, Albert Widmer5 and Hanno Richards5, 1Division of Arthritis & Rheumatic Diseases, Oregon Health & Science University, Portland, OR, 2Clinical Immunology and Rheumatology, Academic Medical Center/University of Amsterdam, Amsterdam, Netherlands, 3University Clinic Benjamin Franklin, Berlin, Germany, 4Novartis Pharmaceuticals Corporation, East Hanover, NJ, 5Novartis Pharma AG, Basel, Switzerland

    Background/Purpose: Secukinumab, an anti–interleukin-17A monoclonal antibody, improved the signs and symptoms of ankylosing spondylitis (AS) in 2 Phase 3, randomized, double-blind, placebo (PBO)-controlled studies, MEASURE…
  • Abstract Number: 653 • 2015 ACR/ARHP Annual Meeting

    Clinical Responses and Improvements in Patient-Reported Outcomes Are Associated with Increased Productivity in the Workplace and at Home in Axial Spondyloarthritis Patients Treated with Certolizumab Pegol

    Désirée van der Heijde1, Juergen Braun2, Martin Rudwaleit3, Oana Purcaru4 and Arthur Kavanaugh5, 1Leiden University Medical Center, Leiden, Netherlands, 2Rheumazentrum Ruhrgebiet, Herne, Germany, 3Klinikum Bielefeld, Bielefeld, Germany, 4UCB Pharma, Brussels, Belgium, 5University of California San Diego, La Jolla, CA

    Background/Purpose: Axial spondyloarthritis (axSpA) includes ankylosing spondylitis (AS) and non-radiographic axSpA (nr-axSpA).1 AS significantly affects patient (pt) workplace productivity in both performance and disease-related absenteeism.2…
  • Abstract Number: 1691 • 2015 ACR/ARHP Annual Meeting

    The Presence of Fibromialgia May Influence the Clinimetric Evaluation of Patients with Ankylosing Spondylitis, but Has No Impact on Disease Activity Assessment

    Emilio Buschiazzo1, Natalia Zamora2, Fernando Andres Sommerfleck3, Romina Rojas Tessel4, Mariana Benegas5, Pablo Arturi6,7, Maria Elena Crespo4, Emilce Schneeberger8 and Gustavo Citera2, 1Rheumatology, Hospital Sr Del Milagro, Salta, Argentina, 2Rheumatology, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 3Rheumatologia, Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina, 4Hospital Sr Del Milagro, Salta, Argentina, 5Sanatorio Mitre, Buenos Aires, Argentina, 6Rheumatology, Instituto de Rehabilitacion Psicofisica and Fundacion Reumatologica Argentina, Buenos Aires, Argentina, 7Rheumatology, Hospital Italiano de La Plata, La Plata, Argentina, 8Instituto de Rehabilitación Psicofísica, Buenos Aires, Argentina

    Background/Purpose: Fibromyalgia (FM) can be present concomitantly in patients with Ankylosing Spondylitis (AS). It may overestimate the evaluation of disease activity, resulting in more intensive…
  • Abstract Number: 2062 • 2015 ACR/ARHP Annual Meeting

    How Reliable Is Self-Evaluation of Symptoms of Inflammatory Back Pain By Patients?

    Denis Poddubnyy1, Inge Spiller1, Joachim Sieper1 and Martin Rudwaleit1,2, 1Charité Universitätsmedizin Berlin, Berlin, Germany, 2Klinikum Bielefeld, Bielefeld, Germany

    Background/Purpose: Inflammatory back pain (IBP) is regarded as an important clinical parameter of axial spondyloarthritis (axSpA) and is often used in a diagnostic approach. Usually…
  • « Previous Page
  • 1
  • …
  • 44
  • 45
  • 46
  • 47
  • 48
  • …
  • 62
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology